Summary:
The purpose of this study is to evaluate the efficacy of pregabalin compared to placebo in reducing neuropathic pain associated with HIV neuropathy.
Qualified Participants Must:
• Be 18 years of age or older
•
Have documented evidence of HIV-1 infection
•
Have documented diagnosis of HIV-associated Distal Symmetrical Polyneuropathy (DSP) with subjective sensory symptom of pain
•
Have pain that starts in the feet
Qualified Participants May Receive:
Study related care, diagnostic tests, and study medication at no cost. Payment for time and travel to the study center may be provided.